BACKGROUND: Functional characterization of mutations involving the SCN5A-encoded cardiac sodium channel has established the pathogenic mechanisms for type 3 long QT syndrome and type 1 Brugada syndrome and has provided key insights into the physiological importance of essential structure-function domains. OBJECTIVE: This study sought to present the clinical and biophysical phenotypes discerned from compound heterozygosity mutations in SCN5A on different alleles in a toddler diagnosed with QT prolongation and fever-induced ventricular arrhythmias. METHODS: A 22-month-old boy presented emergently with fever and refractory ventricular tachycardia. Despite restoration of sinus rhythm, the infant sustained profound neurological injury and died. Using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing, comprehensive open-reading frame/splice mutational analysis of the 12 known long QT syndrome susceptibility genes was performed. RESULTS: The infant had 2 SCN5A mutations: a maternally inherited N-terminal frame shift/deletion (R34fs/60) and a paternally inherited missense mutation, R1195H. The mutations were engineered by site-directed mutagenesis and heterologously expressed transiently in HEK293 cells. As expected, the frame-shifted and prematurely truncated peptide, SCN5A-R34fs/60, showed no current. SCN5A-R1195H had normal peak and late current but abnormal voltage-dependent gating parameters. Surprisingly, co-expression of SCN5A-R34fs/60 with SCN5A-R1195H elicited a significant increase in late sodium current, whereas co-expression of SCN5A-WT with SCN5A-R34fs/60 did not. CONCLUSIONS: A severe clinical phenotype characterized by fever-induced monomorphic ventricular tachycardia and QT interval prolongation emerged in a toddler with compound heterozygosity involving SCN5A: R34fs/60, and R1195H. Unexpectedly, the 94-amino-acid fusion peptide derived from the R34fs/60 mutation accentuated the late sodium current of R1195H-containing Na(V)1.5 channels in vitro.
BACKGROUND: Functional characterization of mutations involving the SCN5A-encoded cardiac sodium channel has established the pathogenic mechanisms for type 3 long QT syndrome and type 1 Brugada syndrome and has provided key insights into the physiological importance of essential structure-function domains. OBJECTIVE: This study sought to present the clinical and biophysical phenotypes discerned from compound heterozygosity mutations in SCN5A on different alleles in a toddler diagnosed with QT prolongation and fever-induced ventricular arrhythmias. METHODS: A 22-month-old boy presented emergently with fever and refractory ventricular tachycardia. Despite restoration of sinus rhythm, the infant sustained profound neurological injury and died. Using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing, comprehensive open-reading frame/splice mutational analysis of the 12 known long QT syndrome susceptibility genes was performed. RESULTS: The infant had 2 SCN5A mutations: a maternally inherited N-terminal frame shift/deletion (R34fs/60) and a paternally inherited missense mutation, R1195H. The mutations were engineered by site-directed mutagenesis and heterologously expressed transiently in HEK293 cells. As expected, the frame-shifted and prematurely truncated peptide, SCN5A-R34fs/60, showed no current. SCN5A-R1195H had normal peak and late current but abnormal voltage-dependent gating parameters. Surprisingly, co-expression of SCN5A-R34fs/60 with SCN5A-R1195H elicited a significant increase in late sodium current, whereas co-expression of SCN5A-WT with SCN5A-R34fs/60 did not. CONCLUSIONS: A severe clinical phenotype characterized by fever-induced monomorphic ventricular tachycardia and QT interval prolongation emerged in a toddler with compound heterozygosity involving SCN5A: R34fs/60, and R1195H. Unexpectedly, the 94-amino-acid fusion peptide derived from the R34fs/60 mutation accentuated the late sodium current of R1195H-containing Na(V)1.5 channels in vitro.
Authors: Connie R Bezzina; Martin B Rook; W Antoinette Groenewegen; Lucas J Herfst; Allard C van der Wal; Jan Lam; Habo J Jongsma; Arthur A M Wilde; Marcel M A M Mannens Journal: Circ Res Date: 2003-02-07 Impact factor: 17.367
Authors: G Alex Papadatos; Polly M R Wallerstein; Catherine E G Head; Rosemary Ratcliff; Peter A Brady; Klaus Benndorf; Richard C Saumarez; Ann E O Trezise; Christopher L-H Huang; Jamie I Vandenberg; William H Colledge; Andrew A Grace Journal: Proc Natl Acad Sci U S A Date: 2002-04-23 Impact factor: 11.205
Authors: Matteo Vatta; Robert Dumaine; Charles Antzelevitch; Ramon Brugada; Hua Li; Neil E Bowles; Koonlawee Nademanee; Josep Brugada; Pedro Brugada; Jeffrey A Towbin Journal: Mol Genet Metab Date: 2002-04 Impact factor: 4.797
Authors: Jianding Cheng; David J Tester; Bi-Hua Tan; Carmen R Valdivia; Stacie Kroboth; Bin Ye; Craig T January; Michael J Ackerman; Jonathan C Makielski Journal: Physiol Genomics Date: 2011-03-08 Impact factor: 3.107
Authors: Rou-Mu Hu; David J Tester; Ryan Li; Tianyu Sun; Blaise Z Peterson; Michael J Ackerman; Jonathan C Makielski; Bi-Hua Tan Journal: Channels (Austin) Date: 2018 Impact factor: 2.581
Authors: Rou-Mu Hu; Bi-Hua Tan; David J Tester; Chunhua Song; Yang He; Sinisa Dovat; Blaise Z Peterson; Michael J Ackerman; Jonathan C Makielski Journal: PLoS One Date: 2015-04-29 Impact factor: 3.240
Authors: Luciana Sacilotto; Hindalis Ballesteros Epifanio; Francisco Carlos da Costa Darrieux; Fanny Wulkan; Theo Gremen Mimary Oliveira; Denise Tessariol Hachul; Alexandre da Costa Pereira; Mauricio Ibrahim Scanavacca Journal: Arq Bras Cardiol Date: 2017-01 Impact factor: 2.000
Authors: Jie Liu; Jason D Bayer; Roozbeh Aschar-Sobbi; Marianne Wauchop; Danna Spears; Michael Gollob; Edward J Vigmond; Robert Tsushima; Peter H Backx; Vijay S Chauhan Journal: PLoS One Date: 2018-05-23 Impact factor: 3.240